Re: Sabharwal et al.: Early endophthalmitis incidence and risk factors after glaucoma surgery in the Medicare population from 2016 to 2019(Ophthalmology. 2024;131:179-187) Reply

被引：0
|
作者：
Sabharwal, Jasdeep [1 ]
Dun, Chen [2 ]
Woreta, Fasika a. [1 ]
机构：
[1] Johns Hopkins Univ, Wilmer Eye Inst, Sch Med, Dept Ophthalmol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Biomed Informat & Data Sci, Baltimore, MD 21287 USA
来源：
OPHTHALMOLOGY | 2024年 / 131卷 / 09期
关键词：
D O I：
10.1016/j.ophtha.2024.05.020
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：e38 / e38
页数：1
相关论文
共 28 条
  • [1] Early Endophthalmitis Incidence and Risk Factors after Glaucoma Surgery in the Medicare Population from 2016 to 2019
    Sabharwal, Jasdeep
    Dai, Xi
    Dun, Chen
    Chen, Anel
    Ali, Muhammad
    Schein, Oliver D.
    Ramulu, Pradeep Y.
    Makary, Martin
    Johnson, Thomas, V
    Woreta, Fasika
    OPHTHALMOLOGY, 2024, 131 (02) : 179 - 187
  • [2] Re: Du et al.: Incidence of endophthalmitis after corneal transplant or cataract surgery in a Medicare population (Ophthalmology 2014;121:290-8)
    Price, Francis W., Jr.
    Patterson, Larry E.
    Gorovoy, Mark S.
    OPHTHALMOLOGY, 2014, 121 (09) : E46 - E46
  • [3] Re: Schwartz et al.: Intracameral antibiotics and cataract surgery: endophthalmitis rates, cost, and stewardship (Ophthalmology. 2016; 123: 1411-1413) REPLY
    Schwartz, Stephen G.
    Flynn, Harry W., Jr.
    Grzybowski, Andrzej
    Relhan, Nidhi
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2017, 124 (04) : E43 - E44
  • [4] Re: Chang et al.: Incident noninfectious uveitis risk after immune checkpoint treatment (Ophthalmology. 2024;131:867-869)
    Hsu, Alan Y.
    Lin, Chun-Ju
    Chen, Huan-Sheng
    Tsai, Yi-Yu
    OPHTHALMOLOGY, 2024, 131 (08) : e33 - e34
  • [5] Zafar et al.: Endophthalmitis rates among Medicare beneficiaries undergoing cataract surgery between 2011 and 2019 (Ophthalmology. 2022;129:250-257) REPLY
    Zafar, Sidra
    Schein, Oliver D.
    Woreta, Fasika A.
    OPHTHALMOLOGY, 2022, 129 (04) : E40 - E41
  • [6] Re: Floud et al.: Risk factors for cataracts treated surgically in postmenopausal women (Ophthalmology. 2016;123: 1704-1710) REPLY
    Floud, Sarah
    Kuper, Hannah
    Reeves, Gillian K.
    Beral, Valerie
    Green, Jane
    OPHTHALMOLOGY, 2017, 124 (04) : E42 - E42
  • [7] Re: Liu et al.: Enhancement after small-incision lenticule extraction: incidence, risk factors, and outcomes (Ophthalmology. 2017; 124: 813-821) REPLY
    Liu, Yu-Chi
    Mehta, Jodhbir
    OPHTHALMOLOGY, 2017, 124 (11) : E84 - E85
  • [8] Re: Chu et al.: Risk factors and incidence of macular edema after cataract surgery: a database study of 81 984 eyes (Ophthalmology 2016;123:316-323) REPLY
    Chu, Colin J.
    Johnston, Robert L.
    Buscombe, Charlotte
    Sallam, Ahmed B.
    Mohamed, Quresh
    Yang, Yit C.
    OPHTHALMOLOGY, 2017, 124 (02) : E17 - E18
  • [9] Re: Yu et al.: Risk of visual field progression in glaucoma patients with progressive retinal nerve fiber layer thinning (Ophthalmology. 2016;123:1201-1210) REPLY
    Leung, Christopher Kai-Shun
    Weinreb, Robert N.
    OPHTHALMOLOGY, 2017, 124 (04) : E40 - E40
  • [10] Re: Shukla et al.: The risk of optic neuritis following mRNA Coronavirus disease 2019 vaccination compared to Coronavirus disease 2019 infection and other vaccinations (Ophthalmology. 2024;131:1076-1082)
    Yu, Penglin
    Liu, Guangsen
    OPHTHALMOLOGY, 2025, 132 (03) : e41 - e42
123